Meyer Handelman Co. Acquires 30 Shares of Regeneron Pharmace

Meyer Handelman Co. grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,265 shares of the biopharmaceutical company’s stock after acquiring an additional 30 shares during the quarter. Meyer Handelman Co.’s holdings […]

Related Keywords

Christopherr Fenimore , Andrewj Murphy , Sanfordc Bernstein , , York Mellon Corp , Regeneron Pharmaceuticals , Barclays , Quarter For Regeneron Pharmaceuticals , News Ratings For Regeneron Pharmaceuticals Daily , Exchange Commission , Northern Trust Corp , Regeneron Pharmaceuticals Stock Down , Nasdaq , Meyer Handelman Co , Morgan Stanley , Cantor Fitzgerald , Jefferies Financial Group , Regeneron Pharmaceuticals Inc , Meyer Handelman , Free Report , Street Corp , Trust Corp , New York Mellon Corp , Pharmaceuticals Stock Down , Get Free Report , Financial Group , Visit Holdingschannel , Regeneron Pharmaceuticals Daily , Nasdaq Regn , Regn , Medical , 75886f10 , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,